Page last updated: 2024-08-22

tiletamine hydrochloride and Leukemia, T-Cell

tiletamine hydrochloride has been researched along with Leukemia, T-Cell in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aizawa, S; Higashihara, M; Horie, R; Ishida, T; Kamihira, S; Kikuchi, H; Koga, S; Maruyama-Nagai, M; Ohsugi, T; Okayama, A; Shoda, M; Umezawa, K; Uozumi, K; Utsunomiya, A; Watanabe, M; Watanabe, T; Yamada, Y; Yamaguchi, K	1
Horie, R; Ishida, T; Kumasaka, T; Ohsugi, T; Okada, S; Umezawa, K; Watanabe, T; Yamaguchi, K	1

Other Studies

2 other study(ies) available for tiletamine hydrochloride and Leukemia, T-Cell

Article	Year
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood, 2005, Oct-01, Volume: 106, Issue:7 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Caspases; Cell Cycle; Cell Line; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Cyclohexanones; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Human T-lymphotropic virus 1; Humans; Immunoblotting; Immunohistochemistry; Jurkat Cells; K562 Cells; Leukemia-Lymphoma, Adult T-Cell; Leukemia, T-Cell; Leukocytes, Mononuclear; Male; Mice; Mice, SCID; Microscopy, Fluorescence; Molecular Weight; NF-kappa B; Proviruses; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Time Factors; Tumor Suppressor Protein p53	2005
Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines. Cancer letters, 2007, Nov-18, Volume: 257, Issue:2 Topics: Adult; Animals; Apoptosis; Benzamides; beta 2-Microglobulin; Cell Line, Tumor; Cyclohexanones; Gene Products, tax; Human T-lymphotropic virus 1; Humans; Leukemia, T-Cell; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays	2007

Article

Year

Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.

Blood, 2005, Oct-01, Volume: 106, Issue:7

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Caspases; Cell Cycle; Cell Line; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Cyclohexanones; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Human T-lymphotropic virus 1; Humans; Immunoblotting; Immunohistochemistry; Jurkat Cells; K562 Cells; Leukemia-Lymphoma, Adult T-Cell; Leukemia, T-Cell; Leukocytes, Mononuclear; Male; Mice; Mice, SCID; Microscopy, Fluorescence; Molecular Weight; NF-kappa B; Proviruses; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Time Factors; Tumor Suppressor Protein p53

2005

Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines.

Cancer letters, 2007, Nov-18, Volume: 257, Issue:2

Topics: Adult; Animals; Apoptosis; Benzamides; beta 2-Microglobulin; Cell Line, Tumor; Cyclohexanones; Gene Products, tax; Human T-lymphotropic virus 1; Humans; Leukemia, T-Cell; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays

2007